Healthcare -
Biotechnology - NASDAQ - US
$ 42.02
-6.46 %
$ 3.35 B
Market Cap
-11.21
P/E
AKRO - REVENUE
Revenue AKRO - Akero Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR